FDA approves Epclusa as pan-genotypic single-tablet regimen for chronic HCV infection June 29, 2016 No Comments
European Commission approves Avastin plus Tarceva for advanced NSCLC with EGFR-activating mutations June 9, 2016 No Comments
Afinitor receives approval in the E.U. for the treatment of advanced GI and lung NET June 6, 2016 No Comments
RSS